Company Filing History:
Years Active: 2015
Title: Innovations of Lih-Geeng Chen
Introduction
Lih-Geeng Chen is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of medical science, particularly in the area of anti-bacterial treatments and leukemia therapies. His innovative work has the potential to impact the lives of many patients suffering from serious infections and diseases.
Latest Patents
Lih-Geeng Chen holds a patent for an "Anti-bacterial infection, inflammation, and leukemia composition and use thereof." This patent describes a method of inhibiting the growth of Gram-positive bacteria by administering an effective amount of Tellimagrandin II, along with its pharmaceutically acceptable salt, enantiomer, isomer, or tautomer. The method specifically targets methicillin-resistant bacteria. Additionally, it outlines a method for treating sepsis and leukemia using the same compound, showcasing its versatility and therapeutic potential.
Career Highlights
Lih-Geeng Chen is affiliated with Kaohsiung Medical University, where he continues to engage in research and development. His work is characterized by a commitment to advancing medical treatments and improving patient outcomes. With a focus on innovative solutions, he has established himself as a key figure in his field.
Collaborations
Lih-Geeng Chen collaborates with esteemed colleagues, including Yen-Hsu Chen and Chin Hsu. These partnerships enhance the research efforts and contribute to the development of effective medical solutions.
Conclusion
Lih-Geeng Chen's contributions to medical science through his innovative patents and collaborations highlight his dedication to improving healthcare. His work in developing treatments for bacterial infections and leukemia is a testament to the impact of innovation in medicine.